December 8, 2020. By Scott Murdoch and Sophie Yu. HONG KONG (Reuters) – JD Health International Inc saw its stock soar 65% above its issue price in its Hong Kong trading debut on Tuesday, as investors bet on the growth prospects of a healthcare business boosted by the COVID-19 pandemic. JD Health is a subsidiary of e-commerce giant JD.
